Tech Company Financing Transactions
Viz Funding Round
On 10/24/2019, Viz received $50 million in Series B funding from Greenoaks Global, CRV and GV.
Transaction Overview
Company Name
Announced On
10/24/2019
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
Greenoaks Global (Lead Investor) (Neil Shah)
Kleiner Perkins Caufield & Byers (Mamoon Hamid)
Proceeds Purpose
This round of funding will enable us to expand the benefits of Synchronized Care to more disease states and geographies, democratizing the quality of health care globally.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
555 De Haro St. 400
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 10/24/2019: Koan venture capital transaction
Next: 10/24/2019: FairMarkIT venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs